您搜索了: antikoagulacijo (斯洛文尼亚语 - 英语)

antikoagulacijo.
close monitoring of anticoagulation levels is warranted.

indikacija za antikoagulacijo
indication for anticoagulation

natančno je treba spremljati antikoagulacijo.
close monitoring of anticoagulation levels is warranted.

intravensko dajanje bivalirudina v nekaj minutah povzroči merljivo antikoagulacijo.
intravenous administration of bivalirudin produces measurable anticoagulation within minutes.

med prehajanjem na alternativen antikoagulant morate zagotoviti neprekinjeno zadostno antikoagulacijo.
continuous adequate anticoagulation should be ensured during any transition to an alternate anticoagulant.

pri uporabi zdravila pradaxa na splošno ni potrebno rutinsko spremljati antikoagulacijo.
pradaxa does not in general require routine anticoagulant monitoring.

klinične študije kažejo, da bivalirudin omogoča zadostno antikoagulacijo med postopkom pci.
in clinical studies bivalirudin has been shown to provide adequate anticoagulation during pci procedures.

povečanje odmerka zdravila lojuxta lahko povzroči supraterapevtsko antikoagulacijo, zmanjšanje pa subterapevtsko antikoagulacijo.
increases in the dose of lojuxta may lead to supratherapeutic anticoagulation, and decreases in the dose may lead to subtherapeutic anticoagulation.

za katetra pri bolnikih, ki so med pci za antikoagulacijo prejemali le fondaparinuks v primerjavi s kontrolo.
ho clinical trials have shown a low but increased risk of guiding catheter thrombus in patients treated with fondaparinux for anticoagulation during pci compared to control.

Čeprav je treba visoke vrednosti aptČ razlagati previdno, kaže visoka vrednost aptČ pri bolniku na antikoagulacijo.
although high aptt values should be interpreted with caution, a high aptt value indicates that the patient is anticoagulated.

ravni r- varfarina se lahko znižajo, kar povzroči zmanjšano antikoagulacijo zaradi indukcije cyp1a2 in cyp2c9, ki jo povzroča ritonavir.
interaction with indinavir/ ritonavir not studied r-warfarin levels may be decreased leading to reduced anticoagulation due to induction of cyp1a2 and cyp2c9 by ritonavir.

klinična preskušanja so pokazala majhno, vendar pa povečano tveganje za pojav trombusa vodilnega katetra pri bolnikih, ki so med pci za antikoagulacijo prejemali le fondaparinuks v primerjavi s kontrolo.
clinical trials have shown a low but increased risk of guiding catheter thrombus in patients treated with fondaparinux for anticoagulation during pci compared to control.

refludan se uporablja za antikoagulacijo pri odraslih bolnikih, ki imajo s heparinom izzvano trombocitopenijo (hit) tipa ii in tromboembolijo, ki zahteva zdravljenje z injekcijami antitrombotikov.
refludan is used for anticoagulation in adult patients with heparin-induced thrombocytopenia (hit) type ii and thromboembolic disease requiring injected antithrombotic medicines.

preiskovanci, ki prejemajo varfarin v prisotnosti natrijevega sitaksentanata, dosežejo terapevtsko antikoagulacijo (ciljno mednarodno normalizirano razmerje - international normalised ratio (inr) target) z nižjimi odmerki antikoagulacijskega sredstva.
subjects receiving warfarin achieve therapeutic anticoagulation (international normalised ratio [inr] target) with lower doses of the anticoagulant in the presence of sitaxentan sodium.